The Struggle for Seamless Pharmaceutical Traceability The Food and Drug Administration (FDA) has recently announced a series of delays and guidelines for the implementation of the Drug Supply Chain Security Act (DSCSA). This move is aimed at addressing the critical issue of data quality, which has been a major hurdle in achieving seamless pharmaceutical traceability..
Introduction The pharmaceutical industry has long been plagued by issues related to counterfeit drugs, regulatory noncompliance, and supply chain inefficiencies..
Stay up-to-date with our latest news, articles, and exclusive offers. Join our community and never miss an important update!